¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"neutral theory of molecular evolution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • molecular grating
    ºÐÀÚ°ÝÀÚ
  • molecular heat
    ºÐÀÚ¿­
  • molecular layer
    ºÐÀÚÃþ
  • molecular magnet
    ºÐÀÚÀÚ¼®
  • molecular marker
    ºÐÀÚÇ¥ÁöÀÚ
  • molecular mimicry
    ºÐÀÚ¸ð¹æ
  • molecular neurobiology
    ºÐÀڽŰæ»ý¹°ÇÐ
  • molecular orientation
    ºÐÀÚ¹èÇâ
  • molecular physiology
    ºÐÀÚ»ý¸®ÇÐ
  • molecular radiation biology
    ºÐÀÚ¹æ»ç¼±»ý¹°ÇÐ
  • molecular refraction
    ºÐÀÚ±¼Àý
  • molecular sieve
    ºÐÀÚü
  • molecular tumbling rate
    ºÐÀÚÅÒºí¸µ·ü
  • molecular weight
    ºÐÀÚ·®
  • molecular weight determination
    ºÐÀÚ·®ÃøÁ¤
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • alternation theory
    ±³¹ø¼³
  • backward failure theory
    ÈĹæÀå¾Ö¼³
  • centrifugal sprouting theory
    ¿ø½É½ÏÆ·¿ò¼³, ¿ø½É¹ß¾Æ¼³
  • clonal selection theory
    Ŭ·Ð¼±Åü³
  • conditioning theory
    Á¶°ÇÈ­ÀÌ·Ð
  • convergence-projection theory
    ÆøÁÖÅõ»ç¼³
  • corpuscular theory
    ÀÔÀÚ¼³
  • countercurrent theory
    ¿ª·ù¼³, ´ëÇâ·ù¼³
  • cross-linking theory
    ±³Â÷¿¬°üÀÌ·Ð
  • developmental theory
    ¹ß´ÞÀÌ·Ð
  • dichotomous theory
    À̺йýÇм³
  • dipole theory
    ½Ö±Ø¼³
  • double-axis theory
    ÀÌÁßÃàÀÌ·Ð
  • enzyme trace substance theory
    È¿¼ÒÈçÀû¹°¼³
  • error theory
    Âø¿ÀÀÌ·Ð
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • molecular attraction
    ºÐÀÚÀηÂ(ÝÂí­ìÚæ³).
  • molecular biology
    ºÐÀÚ»ý¹°ÇÐ
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • molecular clock
    ºÐÀÚ»ý¹°ÇÐÀû ½Ã°è
  • molecular colloid
    ºÐÀÚ(ÝÂí­)ÄÝ·ÎÀ̵å.
  • molecular compound
    ºÐÀÚÈ­ÇÕ¹°(ÝÂí­ ûùùêÚª).
  • molecular conductivity
    ¸ôÀüµµÀ² (¡­îîÓôëÒ).
  • molecular death
    ºÐÀÚ»ç(ÝÂí­ÞÝ).
  • molecular depression
    ºÐÀÚ°­ÇÏ(¡­Ë½ù»).
  • molecular disease
    ºÐÀÚº´(ÝÂí­Ü»).
  • molecular dispersion
    ºÐÀںлê(¡­ÝÂߤ).
  • molecular distillation
    ºÐÀÚÁõ·ù(¡­ñúë§).
  • molecular elevation
    ºÐÀÚ»ó½Â(¡­ß¾ã°).
  • molecular extinction coefficient
    ºÐÀÚ¼Ò¸ê°è¼ö(¡­á¼ØþÌõâ¦).
  • molecular fat
    ºÐÀÚ¼º Áö¹æ(¡­àõò·Û¸).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • number-average molecular weight
    ¹«Æò±ÕºÐÀÚ·®(ÙíøÁгÝÂí­Õá)
  • target molecular weight
    Ç¥ÀûºÐÀÚ·® (øöîÜÝÂí­Õá)
  • viscosity-average molecular weight
    Á¡µµ(ïÄÓø)Æò±Õ ºÐÀÚ·®(øÁгÝÂí­Õá)
  • weight-average molecular weight
    ¹«°ÔÆò±Õ(øÁг) ºÐÀÚ·®(ÝÂí­Õá)
  • z-average molecular weight
    z Æò±ÕºÐÀÚ·® (øÁгÝÂí­Õá)
  • accumulation theory
    ´©Àû·Ð (ÒéîÝÖå)
  • active aldehyde theory
    Ȱ¼º(üÀàõ)¾Ëµ¥ÇÏÀ̵å·Ð(Öå)
  • Bronsted-Lowry theory
    ºê·Ð½ºÅ×µå Ã˸ŷÐ(õºØÚÖå)
  • Burnet's theory
    ¹ö³Ý ·Ð(Öå)
  • Busch theory
    ºÎ½¬ ·Ð(Öå)
  • cholesterol intoxication theory
    ÄÝ·¹½ºÅ×·Ñ Áßµ¶ÀÌ·Ð(ñéÔ¸ìµÖå)
  • clonal selection theory
    Ŭ·Ð ¼±Åà ÀÌ·Ð(àÔ÷ÉìµÖå)
  • collision theory
    Ãæµ¹ÀÌ·Ð(õúÔÍ×âÖå)
  • convergence theory of cancer
    "¾Ï ¼ö·Å·Ð(äßâ¥Ö°Öå),(ÔÒ) Greenstein hypothesis"
  • crystal field theory
    °áÁ¤ Àå·Ð(Ì¿ïÜíÞÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
NEP negative expiratory pressure; nephrology; neutral endopeptidase; no evidence of pathology
neut neuter, neutral; neutrophil
NF nafcillin; National Formulary; nephritic factor; neurofibromatosis; neurofilament; neutral fraction;...
NGL neutral glycolipid
NL neural lobe; neutral lipid; nodular lymphoma; normal; normal libido, normal limits
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
NDF Neutral detergent fiber
NDF Neutral detergent fibre
NL Neutral lipid
NEP Neutral metalloendopeptidase
N-SMase Neutral sphingomyelinase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chemo-parasitic theory
    È­ÇÐ ¼¼±Õ¼³
    ¿ì½ÄÀÇ ¿øÀο¡ °üÇÏ¿© Miller°¡ ¼¼¿î Çм³. ¿ì½ÄÀÇ ¹ß»ýÀº Ä¡¾ÆÀÇ ÁÖü¸¦ ÀÌ·é ¼®È¸¿°ÀÇ Å»È¸À̰í, ±× ¿øÀÎÀÌ µÇ´Â »êÀº À½½Ä¹° Áß¿¡ Æ÷ÇԵǾî Àִ ź¼öÈ­¹°À» ±¸°­³»ÀÇ ¼¼±ÕÀÌ ¹ßÈ¿ÇϹǷΠÀÎÇØ¼­ »ý±â´Â À¯±â»êÀ̶ó´Â °¡¼³À» ¼¼¿ü´Ù. Miller´Â ¿ì½Ä Á¶Á÷À» È­ÇÐÀûÀ¸·Î ºÐ¼®ÇÏ°í ±×°Í¿¡ Æ÷ÇԵǾî ÀÖ´Â Ä®½·°ú À¯±âÁúÀÇ ¾çÀÌ ÀÌ»óÇÏ°Ô °¨¼ÒµÇ¾î ÀÖ´Â °ÍÀ» ¾Ë¾Ò´Ù. Áï ¿ì½Ä Ç¥ÃþºÎÀÇ ¿¬È­ »ó¾ÆÁúÀº Á¤»óÀÇ Ä¡Áú¿¡ ºñÇÏ¿© 92.5%ÀÇ Ä®½·°ú 39.4%ÀÇ À¯±âÁúÀÌ ¼Õ½ÇµÇ¾î ÀÖ°í ¿ì½Ä ½ÉºÎ¿¡¼­´Â 22.0%ÀÇ Ä®½· »ó½ÇÀ» ³ªÅ¸³Â´Ù. ±×·¯¹Ç·Î ±×´Â ½ÇÇèÀ» ÅëÇÏ¿© Ä¡¾Æ¿¡ À¯±â»ê°ú »§°¡·ç¸¦ ¼¯Àº °ÍÀ» ¾È¿¡ ºÙ¿© ³õÀº °á°ú, »ýÈ­ÇÐÀûÀ¸·Î ¿ì½Ä°ú ºñ½ÁÇÑ »óŰ¡ ÀϾ´Â °ÍÀ» ±ú´Ý°í, ¿ì½ÄÀÇ °æ¿ì´Â »êÀÌ Å« ÀÛ¿ëÀ» Çϸç, ±× À¯±â»êÀº »ó¾Æ¼¼°ü³»³ª Ä¡¾ÆÀÇ Ç¥¸é¿¡¼­ º¼ ¼ö ÀÖ´Â ´ÙÁ¾ ´Ù¾çÀÇ ¼¼±Õ¿¡ ÀÇÇØ¼­ À½½Ä¹° Àܻ翡 Æ÷ÇÔµÈ Åº¼öÈ­¹°ÀÇ ¹ßÈ¿¿¡ ÀÇÇÑ °ÍÀ̶ó°í »ý°¢ÇÏ¿´À¸³ª ±×´Â ±× ÁÖ¿ªÀ» ¸ÃÀº ¼¼±ÕÀÌ ¹«¾ùÀΰ¡´Â ¾ð¸íÇÏÁö ¾Ê¾Ò´Ù. ÀÌ È­ÇÐ ¼¼±Õ¼³Àº Èļ¼±îÁö °­ÇÑ ¿µÇâÀ» ¹ÌÄ¡°í ¿ì½ÄÀÇ ¼¼±ÕÇÐÀû ¿¬±¸ÀÇ ÁÖ·ù¸¦ ÀÌ·ç¾î ¿Ô´Ù.
  • clonal selection theory
    Ŭ·Ð ¼±Åü³
  • Combinational theory
    Á¶ÇÕ¼³
    Ç×ü ¹ßÇöÀÇ ´Ù¾ç¼ºÀ» ¼ø¿­ Á¶ÇÕ¿¡¼­ ±¸ÇÏ´Â Çм³.
  • contagium theory
    Àü¿°¼³, °¨¿°¼³
  • doublet theory
    ÀÌÁß±Ø ¼³
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • epoigenetic theory
    Èļº¼³
  • error accumulation theory
    ¿ÀÂ÷ ´©Àû¼³
    ³ëÈ­ÀÇ ¿øÀÎÁõ.
  • fluid mosaic theory
    À¯µ¿ ¸ðÀÚÀÌÅ© ¼³
  • ionic theory
    À̿¼³
    Àü·ù´Â ÀÌ¿ÂÀ» ¿î¹ÝÇÏ´Â ¿ªÇÒ¸¸À» Çϸç, Àü·ù¿Í´Â °ü°è¾øÀÌ ÀüÇØÁú ¿ë¾×Àº Ç×»ó ÀÏÁ¤ÇÑ Àü¸®µµ·Î¼­ Àü¸®ÇÏ¿© ÀÖ´Ù´Â ¼³.
  • Jackson's theory
    Àè½¼ ¼³
    ÀηùÀÇ ³ú¼ö´Â °¡Àå »óºÎ¿¡ ÀÖÀ»¼ö·Ï ÁøÈ­ÇÑ °ÍÀÌ´Ù.
  • Kubelka-Munk theory
    Äíº§Å°-¸ÛÅ©¼³
  • libido theory
    ¸®ºñµµ Çм³, ¼º¿å¼³
    S. ÇÁ·ÎÀÌÆ®´Â ¸®ºñµµ°¡ »çÃá±â¿¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀÌ ¾Æ´Ï¶ó ž¸é¼­ºÎÅÍ ¼­¼­È÷ ¹ß´ÞÇÏ´Â °ÍÀ̶ó°í »ý°¢ÇÏ¿´´Ù. Áï ¼º º»´ÉÀº ±¸¼ø±â, Ç×¹®±â¸¦ ÅëÇØ ¹ß´ÞÇÏ´Ù°¡ 5¼¼°æ ÀýÁ¤¿¡ À̸¥ ÈÄ, ¾ï¾ÐÀ» ¹Þ¾Æ ÀáÀç±â¿¡ À̸£°í, »çÃá±â¿¡ ´Ù½Ã ¼º¿åÀ¸·Î ³ªÅ¸³­´Ù°í ÇÑ´Ù. ±×·¯³ª ¸®ºñµµ´Â, Áßµµ¿¡¼­ ¹ß´ÞÀÌ ÁßÁöµÇ±âµµ Çϰí, ¿ÏÀüÈ÷ ¹ß´ÞÇß´Ù°¡ °Å²Ù·Î µÇµ¹¾Æ°¡´Â °æ¿ìµµ ÀÖ´Ù. ÀÌ»ó ¼º¿å
  • menophylectic theory
    ÀÏ¿ø¼³
  • MIE theory
    MIE ¼³
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
neutral stain <technique> A compound of an acid stain and a basic stain, such as the eosinate of methylene blue, in which the anion and cation each contains a chromophore group.
Synonym: salt dye.
(05 Mar 2000)
neutral stimulus When paired with the unconditioned stimulus in simultaneous presentation to an organism, capable of eliciting a given response.
(05 Mar 2000)
neutral zone In dentistry, the potential space between the lips and cheeks on one side and the tongue on the other; natural or artificial teeth in this zone are subject to equal and opposite forces from the surrounding musculature.
(05 Mar 2000)
day neutral plant <botany> Plants that flower regardless of day length.
(09 Oct 1997)
lens neutral proteinase <enzyme> Degrades alpha 2-crystallin; requires ca and mg; cleaves phe-ser bond in bradykinin; similar enzyme found in human lung
Registry number: EC 3.4.24.5
Synonym: neutral proteinase 24.5
(26 Jun 1999)
relative molecular mass The sum of the atomic weight's of all the atoms constituting a molecule; the mass of a molecule relative to the mass of a standard atom, now 12C (taken as 12.000). Relative molecular mass (Mr) is the mass relative to the dalton and has no units.
See: atomic weight.
Synonym: molecular mass, molecular weight ratio, relative molecular mass.
(05 Mar 2000)
gram-molecular weight Molecular weight expressed in grams.
Compare: mole.
(05 Mar 2000)
cloning, molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells.
(12 Dec 1998)
models, molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures.
(12 Dec 1998)
molecular <chemistry> Of, pertaining to or composed of molecules: a very small mass of matter.
(18 Nov 1997)
molecular behaviour <psychology> Behaviour described in small response units rather than larger ones; a specific response.
Compare: molar behaviour.
(05 Mar 2000)
molecular biology <study> The study of the biochemistry of cells, it is closely linked to cell biology, in particular the biochemistry of DNA and cogeners.
(16 Dec 1997)
molecular biophysics Biophysics concerned with membrane processes, conformational and configurational properties of macromolecules, bioelectrical phenomena, etc.
(05 Mar 2000)
molecular chaperones A family of cellular proteins that mediate the correct assembly or disassembly of other polypeptides, and in some cases their assembly into oligomeric structures, but which are not components of those final structures. It is believed that chaperone proteins assist polypeptides to self-assemble by inhibiting alternative assembly pathways that produce nonfunctional structures. Some classes of molecular chaperones are the nucleoplasmins, the chaperonins, the heat-shock proteins 70, and the heat-shock proteins 90.
(12 Dec 1998)
molecular clock This term has two separate uses.
1. <molecular biology> The rate of fixation of mutations in DNA and thus times the rate of genetic diversification.
2. <cell biology> A biological system capable of maintaining up a timing rhythm or pulse. All such clocks are thought to be entrained by a natural oscillator such as the diurnal rhythm.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • quantum theory
    ¾çÀÚ·Ð
  • stress theory
    (ij³ª´ÙÀÇ H,Selye ±³¼ö ÁÖâÀÇ)½ºÆ®·¹½º Çм³
  • theory
    Çм³;¼³;ÀÌ·Ð;(Ź»óÀÇ)°ø·Ð
  • transformation theory
    º¯Çü¼³
  • trickledown theory
    Æ®¸®Å¬´Ù¿î ÀÌ·Ð(´ë±â¾÷¿¡ÀÇ ÀçÁ¤Àû ¿ì´ë´Â Áß¼Ò±â¾÷À̳ª ¼ÒºñÀÚ¿¡°Ô ÆÄ±ÞÈ¿°ú¸¦ Áشٴ ¼³)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á